Veterans a focus of Homeless Coalition efforts

Worse Prostate Cancer Outcomes With 5-Alpha-Reductase Inhibitors Just last week, a new analysis showed that men with BRCA2 mutations had a higher rate of late-stage prostate cancer at the time of diagnosis and worse outcomes. In addition, drugs called PARP.

But for veterans with misconduct-related discharges, the rate was far higher: from 1.3 percent at an initial VA visit to 9.8 percent within five years. According to the National Coalition.